The Spanish language version of the TAPS tool: protocol for a validation and implementation study in primary care
- PMID: 37974265
- PMCID: PMC10652452
- DOI: 10.1186/s13722-023-00423-9
The Spanish language version of the TAPS tool: protocol for a validation and implementation study in primary care
Abstract
Background: The TAPS Tool ("Tobacco, Alcohol, Prescription drug, and illicit Substance use") is a screening and brief assessment for detecting unhealthy substance use in healthcare settings that was developed by the National Institute on Drug Abuse Clinical Trials Network and validated in a multisite study. Our team developed a Spanish language version of the TAPS Tool that supports provider- and self-administration screening using a mobile/web-based platform, the TAPS Electronic Spanish Platform (TAPS-ESP).
Methods: This article describes the protocol and rationale for a study to validate the TAPS-ESP in a sample of Spanish-speaking primary care patients recruited from a network of community-based clinics in Texas (target N = 1,000). The TAPS-ESP will be validated against established substance use disorder diagnostic measures, alternative screening tools, and substance use biomarkers. The study will subsequently examine barriers and facilitators to screening with the TAPS-ESP from a provider workflow perspective using qualitative interviews with providers.
Discussion: Validating a Spanish language version of the TAPS Tool could expand access to evidence-based, linguistically accurate, and culturally relevant substance use screening and brief assessment for an underserved health disparity population.
Trial registration: The study was registered with www.
Clinicaltrials: gov : NCT05476588, 07/22/2022.
Keywords: Culturally relevant; Linguistically accurate; Primary care; SUD screening; Spanish; Validity.
© 2023. The Author(s).
Conflict of interest statement
The authors declare that they have no competing interests.
Figures
Similar articles
-
Development and Feasibility of a Spanish Language Version of the Tobacco, Alcohol, Prescription Drug, and Illicit Substance Use (TAPS) Tool.J Addict Med. 2021 Jan-Feb 01;15(1):61-67. doi: 10.1097/ADM.0000000000000699. J Addict Med. 2021. PMID: 32657958
-
Performance of the Tobacco, Alcohol, Prescription Medication, and Other Substance Use (TAPS) Tool for Substance Use Screening in Primary Care Patients.Ann Intern Med. 2016 Nov 15;165(10):690-699. doi: 10.7326/M16-0317. Epub 2016 Sep 6. Ann Intern Med. 2016. PMID: 27595276 Free PMC article. Clinical Trial.
-
Design of the NIDA clinical trials network validation study of tobacco, alcohol, prescription medications, and substance use/misuse (TAPS) tool.Contemp Clin Trials. 2016 Sep;50:90-7. doi: 10.1016/j.cct.2016.07.013. Epub 2016 Jul 19. Contemp Clin Trials. 2016. PMID: 27444426 Free PMC article. Clinical Trial.
-
Screening and brief intervention for alcohol and other abuse.Adolesc Med State Art Rev. 2014 Apr;25(1):126-56. Adolesc Med State Art Rev. 2014. PMID: 25022191 Review.
-
Screening for Unhealthy Alcohol and Drug Use in General Medicine Settings.Med Clin North Am. 2022 Jan;106(1):13-28. doi: 10.1016/j.mcna.2021.08.002. Med Clin North Am. 2022. PMID: 34823726 Review.
References
-
- Adhikari B, Kahende J, Malarcher A, Pechacek T, Tong V. Smoking-attributable mortality, years of potential life lost, and productivity losses-United States, 2000–2004 (Reprinted from MMWR, vol 57, pg 1226–1228, 2008) JAMA-J Am Med Assoc. 2009;301(6):593–594.